This section features information on all TRANSCAN funded projects by country and funding organization. Click on a country/funding organization to find out what projects have been financed by a specific country/funding organization.
Prediction of Nivolumab action in metastatic renal cancer patients: Treg function, tumoral access and NK interaction as predictive biomarkers of immunotherapy
Subscribe to our Newsletter You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter.
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 964264.
Legal Notice | Privacy Policy